{"id":"https://openalex.org/W170676557","doi":"https://doi.org/10.1080/1120009x.1993.11739222","title":"Serum Methotrexate (MTX) Concentrations and Prognosis in Patients with Osteosarcoma of the Extremities Treated with a Multidrug Neoadjuvant Regimen","display_name":"Serum Methotrexate (MTX) Concentrations and Prognosis in Patients with Osteosarcoma of the Extremities Treated with a Multidrug Neoadjuvant Regimen","publication_year":1993,"publication_date":"1993-04-01","ids":{"openalex":"https://openalex.org/W170676557","doi":"https://doi.org/10.1080/1120009x.1993.11739222","mag":"170676557","pmid":"https://pubmed.ncbi.nlm.nih.gov/8515297"},"language":"en","primary_location":{"id":"doi:10.1080/1120009x.1993.11739222","doi":"https://doi.org/10.1080/1120009x.1993.11739222","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1120009x.1993.11739222","pdf_url":null,"source":{"id":"https://openalex.org/S127202688","display_name":"Journal of Chemotherapy","issn_l":"1120-009X","issn":["1120-009X","1973-9478"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101746409","display_name":"Stefano Ferrari","orcid":"https://orcid.org/0000-0001-6462-6000","observed_orcids":["https://orcid.org/0000-0001-6462-6000"]},"institutions":[{"id":"https://openalex.org/I4210121742","display_name":"Istituto Ortopedico Rizzoli","ror":"https://ror.org/02ycyys66","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210121742","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Ferrari","raw_affiliation_strings":["Sezione di Chemioterapia dei Tumori dell'Apparato Locomotore, Instituti Ortopedici Rizzoli, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sezione di Chemioterapia dei Tumori dell'Apparato Locomotore, Instituti Ortopedici Rizzoli, Bologna, Italy","institution_ids":["https://openalex.org/I4210121742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063299767","display_name":"Val\u00e9ria Paula Sassoli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Sassoli","raw_affiliation_strings":["Servizio Farmacia","Sezione di Chemioterapia dei tumori ossei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servizio Farmacia","institution_ids":[]},{"raw_affiliation_string":"Sezione di Chemioterapia dei tumori ossei","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063424146","display_name":"Lorenza Maria Landi","orcid":"https://orcid.org/0000-0003-2604-6595","observed_orcids":["https://orcid.org/0000-0003-2604-6595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Orlandi","raw_affiliation_strings":["Servizio Laboratorio, Analisi","Sezione di Chemioterapia dei tumori ossei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servizio Laboratorio, Analisi","institution_ids":[]},{"raw_affiliation_string":"Sezione di Chemioterapia dei tumori ossei","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062300869","display_name":"S. Strazzari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Strazzari","raw_affiliation_strings":["Servizio Farmacia","Sezione di Chemioterapia dei tumori ossei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servizio Farmacia","institution_ids":[]},{"raw_affiliation_string":"Sezione di Chemioterapia dei tumori ossei","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068495707","display_name":"Cristina Puggioli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Puggioli","raw_affiliation_strings":["Servizio Farmacia","Sezione di Chemioterapia dei tumori ossei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servizio Farmacia","institution_ids":[]},{"raw_affiliation_string":"Sezione di Chemioterapia dei tumori ossei","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069824958","display_name":"Alberto Battistini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121742","display_name":"Istituto Ortopedico Rizzoli","ror":"https://ror.org/02ycyys66","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210121742","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Battistini","raw_affiliation_strings":["Centro Tumori dell'Apparato Locomotore - Istituti Ortopedici Rizzoli - Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Tumori dell'Apparato Locomotore - Istituti Ortopedici Rizzoli - Bologna, Italy","institution_ids":["https://openalex.org/I4210121742"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008318243","display_name":"Giulia Bacci","orcid":"https://orcid.org/0009-0002-7213-2507","observed_orcids":["https://orcid.org/0009-0002-7213-2507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Bacci","raw_affiliation_strings":["Sezione di Chemioterapia dei Tumori dell'Apparato Locomotore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sezione di Chemioterapia dei Tumori dell'Apparato Locomotore","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4905,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.83498107,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"5","issue":"2","first_page":"135","last_page":"141"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/extremity-osteosarcoma","display_name":"extremity osteosarcoma","score":0.7820000052452087},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8830000162124634},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.8069999814033508},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6830000281333923},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9589999914169312},{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":0.8949999809265137},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9729999899864197},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9589999914169312},{"id":"https://openalex.org/keywords/histological-response","display_name":"histological response","score":0.6309999823570251},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.8005300164222717},{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.7780311703681946},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7409177422523499},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6884326338768005},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5709318518638611},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.5092793703079224},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.47918593883514404},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4709889590740204},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4650135636329651},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3030906319618225},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.2050347924232483},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16092219948768616},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11769437789916992},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.06751945614814758},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.061753809452056885}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005121","descriptor_name":"Extremities","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/1120009x.1993.11739222","doi":"https://doi.org/10.1080/1120009x.1993.11739222","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1120009x.1993.11739222","pdf_url":null,"source":{"id":"https://openalex.org/S127202688","display_name":"Journal of Chemotherapy","issn_l":"1120-009X","issn":["1120-009X","1973-9478"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemotherapy","raw_type":"journal-article"},{"id":"pmid:8515297","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8515297","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chemotherapy (Florence, Italy)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W14799966","https://openalex.org/W756498423","https://openalex.org/W855191455","https://openalex.org/W1902222293","https://openalex.org/W1960987851","https://openalex.org/W1968195674","https://openalex.org/W1981956631","https://openalex.org/W1994117847","https://openalex.org/W2004118732","https://openalex.org/W2055848215","https://openalex.org/W2060688081","https://openalex.org/W2063759313","https://openalex.org/W2113211750","https://openalex.org/W2255287495","https://openalex.org/W2324850315","https://openalex.org/W2441344816"],"related_works":["https://openalex.org/W2153180030","https://openalex.org/W2137872977","https://openalex.org/W2045107319","https://openalex.org/W2004186414","https://openalex.org/W4417287642","https://openalex.org/W2384299534","https://openalex.org/W4417184835","https://openalex.org/W1810454109","https://openalex.org/W1965417875","https://openalex.org/W2031564407"],"abstract_inverted_index":{"SummaryThe":[0],"relationship":[1],"between":[2,157,215,242],"the":[3,9,20,30,63,82,91,108,121,125,139,158,162,181,206,248,253],"serum":[4,76,109,176,213,243,259,275],"concentration":[5],"of":[6,19,33,37,43,55,62,104,154,166,171,192,229,245,267],"methotrexate":[7,44],"and":[8,49,70,168,173,217,247],"prognosis":[10],"has":[11],"been":[12],"studied":[13,65],"in":[14,81,90,164,226,236],"108":[15],"patients":[16,64,83,92,126,140,220,237,254],"with":[17,127,141,239,264],"osteosarcoma":[18,230],"extremities":[21],"treated":[22,238,263],"from":[23,205],"September":[24],"1986":[25],"to":[26,113,120,269],"December":[27],"1989":[28],"at":[29,178],"Chemotherapy":[31],"Department":[32],"Rizzoli":[34],"Hospital.The":[35],"protocol":[36],"neoadjuvant":[38,227],"chemotherapy":[39,198,228],"included":[40],"high":[41],"doses":[42],"(HDMTX)":[45],"adriamycin,":[46],"cisplatinum,":[47],"ifosfamide":[48],"VP-16.":[50],"After":[51],"a":[52,133,189,233],"median":[53],"follow-up":[54],"40.4":[56],"months":[57],"(range":[58],"24-62),":[59],"84":[60],"(77.7%)":[61],"remained":[66,85],"continuously":[67],"disease-free":[68,136],"(CDF)":[69],"24":[71],"relapsed.":[72],"Significantly":[73],"higher":[74,142,190],"mean":[75,122,143],"MTX":[77,110,123,144,207,212,246,258,268,274],"concentrations":[78,145,244,260],"were":[79,221],"observed":[80],"who":[84,93,255],"CDF":[86],"(669.5":[87],"\u03bcmol/1)":[88,96],"than":[89,129,138,186],"relapsed":[94],"(571.9":[95],"(":[97],"p":[98,149],"<":[99,150],".004).":[100],"The":[101,152],"breaking":[102],"point":[103],"prognostic":[105,155],"significance":[106],"for":[107,250],"levels":[111,177,214],"seems":[112],"be":[114,262],"700":[115,130,272],"\u03bcmol/1.":[116],"In":[117,180],"fact,":[118],"according":[119],"concentrations,":[124],"less":[128],"\u03bcmol/1":[131,273],"showed":[132],"significantly":[134],"lower":[135],"survival":[137],"(68.12%":[146],"vs":[147],"94.87%":[148],".0013).":[151],"distribution":[153],"variables":[156],"two":[159],"groups":[160],"was":[161,199],"same":[163],"terms":[165],"site":[167],"histological":[169,194],"type":[170],"tumor":[172],"alkaline":[174],"phosphatase":[175],"diagnosis.":[179],"group":[182],"which":[183],"had":[184],"more":[185],"700\u03bcmol/1":[187],"MTX,":[188],"percentage":[191],"good":[193,216],"response":[195],"after":[196],"primary":[197],"observed.":[200],"This":[201],"is":[202,232],"probably":[203],"independent":[204],"because":[208],"no":[209],"significant":[210],"preoperative":[211],"partially":[218],"responding":[219],"observed.These":[222],"data":[223],"suggest":[224],"that":[225],"there":[231],"correlation,":[234],"even":[235],"multidrug":[240],"regimens,":[241],"prognosis;":[249],"this":[251],"reason":[252],"show":[256],"low":[257],"should":[261],"increased":[265],"amounts":[266],"achieve":[270],"upper":[271],"levels.":[276]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}